Shu-Feng Zhou serves presently a Professor, an Associate Vice President of global medical development, and Associate Dean of international research, Colleges of Pharmacy and Medicine, University of South Florida, Tampa, Fla, USA. Professor Zhou completed his clinical medical training in China in 1989 and obtained his Ph.D. degree in 2001, from the School of Medicine, the University of Auckland, Auckland, New Zealand. Since 2002, Zhou has served as a faculty member for the National University of Singapore, Queensland University of Technology (Australia), and RMIT University (Australia). Zhou’s major research interests are drug metabolism, drug transport, pharmacogenomics, herbal medicines, nanomedicine, drug discovery, and stem cells. Zhou has published more than 320 peer-reviewed papers in various pharmacology and medical journals including New England Journal of Medicine, Cancer Research, Journal of Biological Chemistry, Clinical Pharmacology and Therapeutics, and Clinical Cancer Research. He has also published 16 books and book chapters and more than 200 conference abstracts. His work has been cited more than 6,500 times by other colleagues. He has received more than $15.0 million grants from various funding bodies and industries. To date, he has trained 24 Ph.D. degree students, 12 M.S./honors degree students, and 14 postdoctoral staff. Zhou serves as an Editor-in-Chief or editor for Drug, Healthcare and Patient Safety, Journal of Pharmacogenomics and Pharmacoproteomics, Drug Metabolism Letters, and Current Drug Metabolism and is the Editorial Board Member of 21 medical and pharmacological journals. Zhou has given more than 80 invited seminars/keynote presentations to a variety of academic institutes, government agencies, and high-profile international conferences. He is a recipient of several reputable awards, a member of several national and international professional societies, and a Visiting/Adjunct Professor of multiple reputable research universities.
Biography Updated on 10 September 2012